Toujeo
Diabetes
CommercialMarketed
Key Facts
About Sanofi
Sanofi is one of the world's largest pharmaceutical companies, leveraging artificial intelligence and deep immunology expertise to develop breakthrough treatments and vaccines. With a comprehensive pipeline spanning multiple therapeutic areas and a strong commercial portfolio of established medicines, the company is committed to improving global health outcomes. Their recent focus on AI-powered drug discovery and development positions them at the forefront of pharmaceutical innovation.
View full company profileTherapeutic Areas
Other Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| Lantus | Sanofi | Commercial |
| Semglee (insulin glargine biosimilar) | Viatris | Approved |
| Semglee (Insulin Glargine) | Biocon | Approved |
| Insulin Aspart | Biocon | Phase 3 |
| Liraglutide | Biocon | Phase 3 |
| MK-1293 (insulin glargine biosimilar) | Organon | Approved/Filed |
| Insulin Glargine (Biosimilar) | Gulf Pharmaceutical Industries | Approved/Commercial |
| CYAPO913 | FibroBiologics | Discovery |